Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? (Q41603069)

4 October 2017

1 reference

title

Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? (English)

1 reference

4 October 2017

Ruschitzka FT

1

1 reference

PubMed ID

9313622

4 October 2017

Lüscher TF

series ordinal

2

1 reference

PubMed ID

9313622

4 October 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

4 October 2017

American Heart Journal

1 reference

4 October 2017

134

1 reference

4 October 2017

2 Pt 2

1 reference

4 October 2017

S31-47

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The effects of Ca2+ antagonists on isolated rat and rabbit mesenteric resistance vessels. What determines the sensitivity of agonist-activated vessels to Ca2+ antagonists?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Vascular endothelial cells synthesize nitric oxide from L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Cloning and characterization of inducible nitric oxide synthase from mouse macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Regulation of endothelin-1 expression in normal and transfected endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Differential effects of the calcium antagonist mibefradil in epicardial and intramyocardial coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-derived contracting factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Cloning and expression of a cDNA encoding an endothelin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin is a potent mitogen for rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelins come home to roost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effect of endothelin-1 on calcium channel gating by agonists in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Different Mobilization of Calcium in Endothelin-1 -Induced Contractions in Human Arteries and Veins: Effects of Calcium Antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Signal transduction by receptors with tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effect of cholesterol reduction by simvastatin on progression of coronary atherosclerosis: Design, baseline characteristics, and progress of the Multicenter Anti-Atheroma Study (MAAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The risk of myocardial infarction associated with antihypertensive drug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The effect of diltiazem on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Migration of smooth muscle and endothelial cells. Critical events in restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Pharmacology of smooth muscle cell replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Molecular biology of the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin II receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin-Converting Enzyme: Vascular Endothelial Localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Converting enzyme inhibition in isolated porcine resistance artery potentiates bradykinin relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Different effects of angiotensin-converting enzyme inhibition in human arteries and veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Quinaprilat Induces Arterial Vasodilation Mediated by Nitric Oxide in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-dependent hyperpolarization of canine coronary smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelium-dependent effects of converting-enzyme inhibitors

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Epidemiology of coronary heart disease: the Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Enalapril in the prevention of restenosis following intracoronary intervention in a swine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

Endothelial regulation of vascular tone and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970007-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(97)70007-3

1 reference

4 October 2017

1 reference

PubMed ID

9313622